Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.37%126.14B | 1.83%516.13B | -1.15%118.58B | -3.87%506.87B | -3.40%128.74B | -2.06%129.45B | -4.62%128.72B | -5.44%119.96B | 5.06%527.26B | -0.22%133.27B |
| Cost of revenue | 6.15%107.02B | 1.55%439.16B | -0.64%100.82B | -3.68%432.47B | -2.68%110.16B | -1.58%110.42B | -3.83%110.41B | -6.72%101.47B | 4.63%448.98B | -1.34%113.19B |
| Gross profit | 7.65%19.11B | 3.46%76.97B | -3.94%17.76B | -4.96%74.4B | -7.50%18.57B | -4.78%19.03B | -9.08%18.31B | 2.25%18.49B | 7.62%78.28B | 6.54%20.08B |
| Operating expense | 2.94%17.38B | 4.53%67.43B | 5.32%16.89B | 4.53%64.51B | 3.67%16.23B | 2.27%16.36B | 3.26%15.89B | 9.22%16.03B | 10.99%61.72B | 11.74%15.65B |
| Operating profit | 98.97%1.73B | -3.56%9.54B | -64.49%871M | -40.30%9.89B | -46.98%2.35B | -33.03%2.67B | -49.08%2.42B | -27.87%2.45B | -3.33%16.56B | -8.52%4.43B |
| Net non-operating interest income (expenses) | 2,000.00%105M | 638.00%269M | 129.41%5M | 68.15%-50M | 82.76%-5M | 70.00%-12M | 57.89%-16M | 66.00%-17M | 27.31%-157M | 48.21%-29M |
| Non-operating interest income | 164.91%151M | 160.66%477M | 26.67%57M | 83.00%183M | 50.00%51M | 66.67%45M | 68.00%42M | 221.43%45M | 63.93%100M | 126.67%34M |
| Non-operating interest expense | -11.54%46M | -10.73%208M | -16.13%52M | -9.34%233M | -11.11%56M | -14.93%57M | -7.94%58M | -3.13%62M | -7.22%257M | -11.27%63M |
| Net investment income | -140.19%-86M | -30.95%241M | 55.07%214M | -47.28%349M | 5,750.00%113M | -87.07%19M | -78.65%79M | -6.12%138M | 3,052.38%662M | 33.33%-2M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 447.57%1.01B | 1,132.14%2.42B | 185M | 168.49%196M | -333.33%-21M | 21.88%78M | 139M | 0 | -88.30%73M | 9M |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 150.00%2M | -79.10%-240M | 20.00%-4M | -570.00%-134M | -12,600.00%-127M | 90.48%-2M | 0 | -5M | -115.27%-20M | -150.00%-1M |
| Less:Restructuring and mergern&acquisition | ---- | 98.23%224M | ---- | --113M | ---- | ---- | ---- | ---- | --0 | ---- |
| Less:Other special charges | -150.00%-2M | -23.81%16M | -20.00%4M | 16.67%21M | --14M | -90.00%2M | --0 | --5M | 113.74%18M | --0 |
| Less:Write off | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --2M | --1M |
| Other non-operating income (expenses) | -7.32%38M | -71.43%36M | -44.59%41M | -40.28%126M | -21.43%22M | -106.52%-3M | -67.96%33M | 117.65%74M | 35.26%211M | -15.15%28M |
| Income before tax | 113.80%2.81B | 18.10%12.26B | -50.38%1.31B | -40.13%10.38B | -47.43%2.33B | -34.27%2.75B | -48.80%2.65B | -25.18%2.64B | -2.87%17.33B | -7.86%4.43B |
| Income tax | 48.50%940M | 11.60%4.17B | -38.42%633M | -19.81%3.73B | 80.28%905M | -30.84%859M | -43.98%940M | -16.56%1.03B | -18.78%4.65B | -69.01%502M |
| Net income | 174.67%1.87B | 21.76%8.09B | -57.98%679M | -47.59%6.65B | -63.73%1.43B | -35.72%1.89B | -51.14%1.71B | -29.80%1.62B | 4.64%12.68B | 23.17%3.93B |
| Net income continuous operations | 174.67%1.87B | 21.74%8.09B | -57.98%679M | -47.59%6.65B | -63.74%1.43B | -35.72%1.89B | -51.11%1.71B | -29.80%1.62B | 4.65%12.68B | 23.20%3.93B |
| Noncontrolling interests | 10.81%41M | 57.69%246M | -19.57%37M | 2.63%156M | -34.88%28M | 102.78%73M | -74.29%9M | 21.05%46M | 63.44%152M | 230.77%43M |
| Net income attributable to the company | 183.96%1.82B | 20.92%7.85B | -59.08%642M | -48.21%6.49B | -64.08%1.4B | -37.46%1.82B | -50.88%1.71B | -30.67%1.57B | 4.19%12.53B | 22.32%3.89B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 183.96%1.82B | 20.92%7.85B | -59.08%642M | -48.21%6.49B | -64.08%1.4B | -37.46%1.82B | -50.88%1.71B | -30.67%1.57B | 4.19%12.53B | 22.32%3.89B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 195.17%21.37 | 24.08%90.63 | -59.00%7.24 | -48.20%73.04 | -64.06%15.72 | -37.42%20.47 | -50.88%19.19 | -30.69%17.66 | 5.43%141 | 22.59%43.74 |
| Diluted earnings per share | 193.95%19.43 | 23.58%82.7 | -59.17%6.61 | -48.31%66.92 | -64.17%14.39 | -37.55%18.76 | -51.00%17.58 | -30.78%16.19 | 4.56%129.47 | 22.29%40.16 |
| Dividend per share | 0 | 4.00%52 | 0 | 25.00%50 | 50.00%30 | 0 | 0.00%20 | 0 | 33.33%40 | 0.00%20 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |